SCHEMBL20550603

SCHEMBL20550603

O=C(NC1CCCC1)N1c2nc(-c3cccc(C(F)(F)F)c3)ncc2N2CC[C@H]1C2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.47
▸ GRIN1 Q05586 4/20 0.42
▸ GRIN2B Q13224 4/20 0.42
▸ EPHX2 P34913 1/20 0.41
▸ PAK1 Q13153 1/20 0.41
▸ RPS6KB1 P23443 1/20 0.41
▸ IRAK4 Q9NWZ3 1/20 0.40
▸ KIF11 P52732 1/20 0.40
▸ LMNA P02545 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ HTT P42858 2/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CYP2C9 P11712 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ KMT2A Q03164 2/20 0.38
▸ MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17778371 0.98 ALDH1A1 (0.45) ALDH1A1GRIN1GRIN2BEPHX2PAK1
SCHEMBL20550479 0.97 ALDH1A1 (0.42) ALDH1A1GRIN1GRIN2BPAK1RPS6KB1
SCHEMBL17769468 0.93 ALDH1A1 (0.43) ALDH1A1GRIN1GRIN2BPAK1RPS6KB1
SCHEMBL17769507 0.93 ALDH1A1 (0.43) ALDH1A1GRIN1GRIN2BPAK1RPS6KB1
SCHEMBL17778466 0.88 DPP4 (0.41) ALDH1A1GRIN1GRIN2BIRAK4HTT
SCHEMBL17769444 0.88 DPP4 (0.41) ALDH1A1GRIN1GRIN2BIRAK4HTT
SCHEMBL17768083 0.87 ALDH1A1 (0.43) ALDH1A1GRIN1GRIN2BEPHX2RPS6KB1
SCHEMBL17769661 0.86 IRAK4 (0.39) ALDH1A1GRIN1GRIN2BPAK1RPS6KB1
SCHEMBL19699711 0.86 ALDH1A1 (0.44) ALDH1A1GRIN1GRIN2BEPHX2RPS6KB1
SCHEMBL17768313 0.86 ALDH1A1 (0.44) ALDH1A1GRIN1GRIN2BEPHX2RPS6KB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180319810-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE IP NO 2 LTD (GB) 2018-11-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180319810-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS SIRT1, SIRT3, SIRT2 ALDH1A1 1067/4885GRIN1 4326/4885GRIN2B 4442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback